サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1451694

男性不妊市場レポート：検査タイプ、治療、流通チャネル、エンドユーザー、地域別、2024-2032

Male Infertility Market Report by Test Type, Treatment, Distribution Channel, End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 149 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
男性不妊市場レポート：検査タイプ、治療、流通チャネル、エンドユーザー、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の男性不妊市場規模は2023年に40億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて4.79%の成長率（CAGR）を示し、2032年までに62億米ドルに達すると予測しています。男性不妊の有病率の増加、親になるのが遅れる傾向の高まり、著しい技術進歩、ライフスタイルの進化、不妊症に対する意識の高まり、生殖補助医療技術の合法化などが市場を後押しする主な要因です。

男性不妊とは、男性の生殖器系に関連する要因のために、男性が女性のパートナーを妊娠させることができない状態を指します。多くの場合、精子の生産、質、または分娩に問題があることに起因します。男性不妊の要因としては、精子数の減少、精子の形状や運動率の異常、ホルモンバランスの乱れ、遺伝的要因、精索静脈瘤（陰嚢の静脈の肥大）のような特定の病状などが挙げられます。また、過度の飲酒、喫煙、薬物の使用、肥満などの生活習慣も男性不妊の一因となります。

世界的に男性不妊の罹患率が上昇していることは、市場の重要な促進要因です。ライフスタイルの変化、環境汚染物質、ストレス関連因子がこの増大する懸念の一因となっており、診断・治療ソリューションの必要性が高まっています。さらに、キャリアの目標やその他の人生の願望を追求するために子作りを遅らせるという動向は、男性の年齢関連の不妊問題の高まりにつながっています。このことが、男性不妊治療や生殖補助医療技術の需要に拍車をかけています。これ以外にも、教育キャンペーンやデジタルリソースのおかげで、不妊問題に対する意識が高まり、不妊問題のために医療支援を求める男性が増加しており、市場の成長を促進しています。このほか、座りがちな生活、食生活の乱れ、環境毒素への曝露の増加が精子の質と量の低下に関連しています。こうした要因に対する意識が高まるにつれ、こうした影響を打ち消すための介入策や治療法に対する需要が高まっています。これに伴い、医療技術の進歩により、男性不妊の診断法や治療法の精度が向上しています。精子DNA断片化解析や高度な精子選択法などの革新的技術により、治療成績が向上しています。

男性不妊市場の動向と促進要因：

男性不妊の有病率の増加

座りがちなライフスタイル、環境汚染物質への曝露、高いストレスレベルなど、多くの要因が総体的に男性の不妊症の増加に寄与しています。これらの要因は、精子の生産、質、運動率に悪影響を及ぼす可能性があります。男性不妊の蔓延が認識されるにつれ、正確な診断と効果的な治療法に対する需要が高まっています。夫婦は、これらの懸念に対処するために医学的専門知識を求めており、不妊治療サービスの診察と採用の増加に繋がっています。

子育て延期の動向の高まり

社会規範やキャリア志向の進化により、子育てを遅らせる傾向が勢いを増しています。しかし、加齢の進行は、精子の質の低下やDNAの断片化の増加など、男性の生殖能力の低下と関連しています。この現象は、男性の加齢に関連した不妊の課題を生んでいます。その結果、男性不妊市場では、人生の後半に家庭を築きたいと願う高齢男性の間で、妊孕性の温存や治療オプションに対する需要が急増しています。この動向は、この層特有の要件に対応する専門的介入の必要性を強調しています。

重要な技術的進歩

精子DNA断片化解析のような革新的技術により、精子の質をより包括的に評価することが可能になった。さらに、磁気活性化細胞選別（MACS）のような高度な精子選別法は、受精成功の可能性を高める。これらの技術は、不妊の根本的な原因を特定する精度を向上させ、ヘルスケア専門家に治療計画を調整するための幅広いツールを提供します。技術が進化し続けるにつれて、治療成績が大幅に改善される可能性があり、患者により効果的で個別化された解決策を提供することで、男性不妊市場の成長に貢献します。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 男性不妊の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：検査タイプ別

  • 精子凝集
    • 市場動向
    • 市場予測
  • DNA断片化法
    • 市場動向
    • 市場予測
  • 酸化ストレス解析
    • 市場動向
    • 市場予測
  • コンピューター支援精液分析
    • 市場動向
    • 市場予測
  • 精子透過アッセイ
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：治療別

  • 治療薬
    • 市場動向
    • 市場予測
  • 生殖補助医療と精巣摘出術
    • 市場動向
    • 市場予測

第8章 市場内訳：流通チャネル別

  • 病院薬局
    • 市場動向
    • 市場予測
  • 薬局・ドラッグストア
    • 市場動向
    • 市場予測
  • オンライン薬局
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 病院・クリニック
    • 市場動向
    • 市場予測
  • 不妊治療センター
    • 市場動向
    • 市場予測
  • 調査機関
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Andrology Solutions
    • CinnaGen Co.
    • Halotech DNA
    • SCSA Diagnostics Inc.
    • Vitrolife
    • Zydus Lifesciences Limited
    • Intas Pharmaceuticals Ltd.
    • Endo International plc
図表

List of Figures

  • Figure 1: Global: Male Infertility Market: Major Drivers and Challenges
  • Figure 2: Global: Male Infertility Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Male Infertility Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Male Infertility Market: Breakup by Test Type (in %), 2023
  • Figure 5: Global: Male Infertility Market: Breakup by Treatment (in %), 2023
  • Figure 6: Global: Male Infertility Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Male Infertility Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Male Infertility Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Male Infertility (Sperm Agglutination) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Male Infertility (Sperm Agglutination) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Male Infertility (DNA Fragmentation Technique) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Male Infertility (DNA Fragmentation Technique) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Male Infertility (Oxidative Stress Analysis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Male Infertility (Oxidative Stress Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Male Infertility (Computer Assisted Semen Analysis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Male Infertility (Computer Assisted Semen Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Male Infertility (Sperm Penetration Assay) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Male Infertility (Sperm Penetration Assay) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Male Infertility (Other Test Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Male Infertility (Other Test Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Male Infertility (Medication) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Male Infertility (Medication) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Male Infertility (Assisted Reproductive Technology and Varicocele Surgery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Male Infertility (Assisted Reproductive Technology and Varicocele Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Male Infertility (Hospitals Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Male Infertility (Hospitals Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Male Infertility (Pharmacies and Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Male Infertility (Pharmacies and Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Male Infertility (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Male Infertility (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Male Infertility (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Male Infertility (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Male Infertility (Fertility Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Male Infertility (Fertility Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Male Infertility (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Male Infertility (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Male Infertility (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Male Infertility (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: North America: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: North America: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: United States: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: United States: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Canada: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Canada: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Asia-Pacific: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Asia-Pacific: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: China: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: China: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Japan: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Japan: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: India: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: India: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: South Korea: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: South Korea: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Australia: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Australia: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Indonesia: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Indonesia: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Others: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Others: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Europe: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Europe: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Germany: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Germany: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: France: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: France: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: United Kingdom: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: United Kingdom: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Italy: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Italy: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Spain: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Spain: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Russia: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Russia: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Latin America: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Latin America: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Brazil: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Brazil: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Mexico: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Mexico: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Others: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Others: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Middle East and Africa: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Middle East and Africa: Male Infertility Market: Breakup by Country (in %), 2023
  • Figure 87: Middle East and Africa: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Global: Male Infertility Industry: SWOT Analysis
  • Figure 89: Global: Male Infertility Industry: Value Chain Analysis
  • Figure 90: Global: Male Infertility Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Male Infertility Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Male Infertility Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
  • Table 3: Global: Male Infertility Market Forecast: Breakup by Treatment (in Million US$), 2024-2032
  • Table 4: Global: Male Infertility Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Male Infertility Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Male Infertility Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Male Infertility Market: Competitive Structure
  • Table 8: Global: Male Infertility Market: Key Players
目次
Product Code: SR112024A6416

The global male infertility market size reached US$ 4.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.2 Billion by 2032, exhibiting a growth rate (CAGR) of 4.79% during 2024-2032. The increasing prevalence of male infertility, rising trend of delayed parenthood, significant technological advancements, evolving lifestyles, increasing awareness about infertility, and legalization of assisted reproductive technologies are some of the major factors propelling the market.

Male infertility refers to the condition in which a man is unable to impregnate a female partner due to factors related to his reproductive system. It is often attributed to issues with sperm production, quality, or delivery. Factors that can contribute to male infertility include low sperm count, abnormal sperm shape or motility, hormonal imbalances, genetic factors, and certain medical conditions like varicocele (enlarged veins in the scrotum). Lifestyle factors such as excessive alcohol consumption, smoking, drug use, and obesity can also play a role in male infertility.

The rising incidence of male infertility worldwide is a significant driver for the market. Changing lifestyles, environmental pollutants, and stress-related factors contribute to this growing concern, necessitating the need for diagnostic and treatment solutions. Additionally, the trend of delaying parenthood to pursue career goals and other life aspirations has led to higher age-related fertility issues among men. This has spurred the demand for male infertility treatments and assisted reproductive technologies. Other than this, increasing awareness about fertility issues, thanks to educational campaigns and digital resources, has prompted more men to seek medical assistance for infertility problems, thus driving the market growth. Besides this, sedentary lifestyles, poor dietary habits, and increased exposure to environmental toxins have been linked to declining sperm quality and quantity. As individuals become more conscious of these factors, the demand for interventions and treatments to counteract these effects has risen. In line with this, advancements in medical technologies have improved the accuracy of diagnostic procedures and treatment options for male infertility. Innovative techniques such as sperm DNA fragmentation analysis and advanced sperm selection methods have enhanced treatment outcomes.

Male Infertility Market Trends/Drivers:

Increasing Prevalence of Male Infertility

A multitude of factors, including sedentary lifestyles, exposure to environmental pollutants, and high stress levels, have collectively contributed to a rise in fertility issues among men. These factors can adversely affect sperm production, quality, and motility. As the prevalence of male infertility becomes more recognized, there is a growing demand for accurate diagnostics and effective treatment options. Couples are seeking medical expertise to address these concerns, leading to increased consultations and adoption of fertility services.

Rising Trend of Delayed Parenthood

The trend of delaying parenthood has gained momentum due to evolving societal norms and career aspirations. However, advancing age is associated with a decline in male fertility, including decreased sperm quality and increased DNA fragmentation. This phenomenon has given rise to age-related fertility challenges among men. As a result, the male infertility market is witnessing a surge in demand for fertility preservation and treatment options among older men who wish to start families later in life. This trend emphasizes the need for specialized interventions that cater to the unique requirements of this demographic.

Significant Technological Advancements

Innovative techniques such as sperm DNA fragmentation analysis enable a more comprehensive assessment of sperm quality. Additionally, advanced sperm selection methods, such as magnetic-activated cell sorting (MACS), enhance the chances of successful fertilization. These technologies offer improved accuracy in identifying underlying causes of infertility and provide healthcare professionals with a wider range of tools to tailor treatment plans. As technology continues to evolve, it has the potential to significantly improve outcomes and contribute to the growth of the male infertility market by providing patients with more effective and personalized solutions.

Male Infertility Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global male infertility market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on test type, treatment, distribution channel and end user.

Breakup by Test Type:

Sperm Agglutination

DNA Fragmentation Technique

Oxidative Stress Analysis

Computer Assisted Semen Analysis

Sperm Penetration Assay

Others

DNA fragmentation technique dominates the market

The report has provided a detailed breakup and analysis of the market based on the test type. This includes sperm agglutination, DNA fragmentation technique, oxidative stress analysis, computer assisted semen analysis, sperm penetration assay, and others. According to the report, DNA fragmentation technique represented the largest segment.

The DNA fragmentation technique stands as the largest segment in the market breakup by test type due to its ability to offer deeper insights into male infertility. This technique assesses DNA damage within sperm, providing crucial information about sperm quality. As a result, it has gained prominence in accurately diagnosing the underlying causes of male infertility, guiding tailored treatment approaches for better outcomes.

Breakup by Treatment:

Medication

Assisted Reproductive Technology and Varicocele Surgery

Assisted reproductive technology and varicocele surgery hold the largest market share

A detailed breakup and analysis of the market based on the treatment has also been provided in the report. This includes medication and assisted reproductive technology and varicocele surgery. According to the report, assisted reproductive technology and varicocele surgery accounted for the largest market share.

ART, encompassing techniques like in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), offers couples the opportunity to overcome various fertility challenges, including male factor infertility. The success rates and advancements in ART have positioned it as a leading choice. Varicocele surgery, on the other hand, is a well-established surgical intervention to treat varicoceles, which are dilated veins in the scrotum that can impede sperm production and quality. By surgically correcting varicoceles, blood flow is improved, potentially enhancing sperm production and motility. This procedure has demonstrated positive outcomes in restoring fertility potential. The popularity of these treatments arises from their proven efficacy, leading to their prominent status in the market's treatment landscape.

Breakup by Distribution Channel:

Hospitals Pharmacies

Pharmacies and Drug Stores

Online Pharmacies

Male infertility products are majorly distributed through hospital pharmacies

The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes hospitals pharmacies, pharmacies and drug stores, and online pharmacies. According to the report, hospitals pharmacies represented the largest segment.

Hospitals offer a range of specialized diagnostic facilities, medical expertise, and treatment options under one roof. This makes them a primary destination for patients seeking comprehensive evaluation, consultations with fertility specialists, and advanced interventions, including assisted reproductive technologies (ART) and surgical procedures. Pharmacies play a crucial role by providing access to prescription medications, supplements, and fertility-related products that support male reproductive health. They serve as convenient points of access for patients to obtain prescribed medications for fertility treatment and management. Additionally, pharmacies offer a discreet environment where individuals can access over-the-counter fertility supplements and products that complement treatment plans.

Breakup by End User:

Hospitals and Clinics

Fertility Centers

Research Institutes

Others

Fertility centers account for the majority of the share in the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals and clinics, fertility centers, research institutes, and others. According to the report, fertility centers accounted for the largest market share.

These centers are dedicated to providing a wide range of services specifically tailored to individuals and couples facing fertility challenges. Fertility centers house a team of experienced reproductive endocrinologists, urologists, embryologists, and other specialists who collectively offer advanced diagnostic evaluations, personalized treatment plans, and assisted reproductive technologies (ART) under one roof. The multidisciplinary nature of fertility centers allows for a holistic approach to male infertility, encompassing medical assessments, laboratory analyses, and innovative treatments. These centers offer a supportive environment that addresses the emotional and physical aspects of fertility struggles. The availability of state-of-the-art technologies, cutting-edge procedures, and a comprehensive understanding of male reproductive health positions fertility centers as the preferred choice for individuals seeking expert guidance and successful outcomes in their journey towards overcoming male infertility.

Breakup by Region:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Europe exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Europe accounted for the largest market share.

The region possesses a well-developed healthcare infrastructure, including advanced medical facilities, fertility clinics, and research institutions, enabling efficient diagnosis and treatment of male infertility. Moreover, changing socio-cultural dynamics have led to increased awareness and acceptance of fertility issues, prompting more individuals and couples to seek medical intervention. European countries also prioritize reproductive health and offer comprehensive healthcare coverage, making fertility treatments more accessible to a larger population. The aging population across the region contributes to a growing demand for assisted reproductive technologies (ART) as delayed parenthood becomes more common. Furthermore, the strong presence of Europe in medical research and development fuels innovations in male infertility treatments, attracting both domestic and international patients seeking cutting-edge solutions.

Competitive Landscape:

Leading companies are investing significantly in research and development to create new and improved diagnostic tools, treatments, and technologies for male infertility. This includes developing innovative sperm analysis techniques, medications, and assisted reproductive technologies to enhance treatment outcomes. Additionally, key players often collaborate with academic institutions, research organizations, and healthcare providers to exchange knowledge, share insights, and drive advancements in male infertility diagnostics and treatments. These collaborations foster a synergistic approach to tackling complex challenges and developing comprehensive solutions. Other than this, recognizing the importance of raising awareness about male infertility, industry leaders are actively involved in educational initiatives. They offer information through online platforms, seminars, and healthcare professional training, aimed at increasing understanding of the condition and encouraging timely interventions. Moreover, key players engage in strategic expansion efforts to tap into emerging markets with growing demand for male infertility treatments. By extending their reach, they aim to provide access to advanced diagnostics and therapies to a wider patient population.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Andrology Solutions

CinnaGen Co.

Halotech DNA

SCSA Diagnostics Inc.

Vitrolife

Zydus Lifesciences Limited

Intas Pharmaceuticals Ltd.

Endo International plc.

Recent Developments:

Andrology Solutions has made recent advancements in the field of male infertility, including improvements in the understanding and management of male factor infertility. It has also worked on developing panels for male infertility genes, which have achieved high accuracy in diagnosing copy number variants (CNVs). These advancements contribute to the diagnosis and treatment of male infertility, allowing for more effective interventions and improved outcomes.

Halotech DNA, a leading international biotech company based in Madrid, has introduced innovative DNA fragmentation analysis systems for evaluating sperm quality. These systems are designed to assess the level of DNA damage in sperm cells, which can be a contributing factor to male infertility. This analysis helps in identifying the underlying causes of infertility and guides the selection of appropriate treatment options.

In 2022, SCSA Diagnostics Inc. developed a test called the SCSA (Sperm Chromatin Structure Assay), which is used to evaluate sperm chromatin structure and DNA strand breaks. The SCSA test is a two-fold simultaneous flow cytometry measure of the extent of sperm nuclear single (ss) and double (ds) strand DNA breaks. This test provides unique information about male infertility by assessing the integrity of sperm DNA, which is crucial for successful fertilization and embryo development.

Key Questions Answered in This Report

  • 1. What was the size of the global male infertility market in 2023?
  • 2. What is the expected growth rate of the global male infertility market during 2024-2032?
  • 3. What are the key factors driving the global male infertility market?
  • 4. What has been the impact of COVID-19 on the global male infertility market?
  • 5. What is the breakup of the global male infertility market based on the test type?
  • 6. What is the breakup of the global male infertility market based on the treatment?
  • 7. What is the breakup of the global male infertility market based on the distribution channel?
  • 8. What is the breakup of the global male infertility market based on the end user?
  • 9. What are the key regions in the global male infertility market?
  • 10. Who are the key players/companies in the global male infertility market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Male Infertility Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Sperm Agglutination
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 DNA Fragmentation Technique
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Oxidative Stress Analysis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Computer Assisted Semen Analysis
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Sperm Penetration Assay
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Treatment

  • 7.1 Medication
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Assisted Reproductive Technology and Varicocele Surgery
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospitals Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmacies and Drug Stores
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Fertility Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Andrology Solutions
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 CinnaGen Co.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Halotech DNA
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 SCSA Diagnostics Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Vitrolife
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Zydus Lifesciences Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Intas Pharmaceuticals Ltd.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Endo International plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis